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The mammary epithelium is organized as a bilayer
of luminal and basal/myoepithelial cells. During
pregnancy, the luminal compartment expands for
milk production, while basal cells are thought to
provide structural and contractile support. Here, we
reveal a pregnancy-specific role of basal epithelia
as a central coordinator of lactogenesis. We demon-
strate that genetic deletion of the transcription factor
p63 (Trp63) gene exclusively within basal cells of the
adult gland during pregnancy leads to dramatic
defects in luminal cell proliferation and differentia-
tion, resulting in lactation failure. This phenotype is
explained by direct transcriptional activation of the
epidermal growth factor family ligand gene Nrg1 by
p63 selectively in basal cells, which is required for
luminal ERBB4/STAT5A activation and consequent
luminal progenitor cell maturation. Thus, paracrine
basal-to-luminal cell signaling, controlled by p63 via
NRG1, orchestrates the entire lactation program.
Collectively, these findings redefine the paradigm
for cellular interactions specifying the functional
maturation of the mammary gland.
INTRODUCTION
Mammary glands are epidermal appendages that serve the
highly specialized function of milk production for mammalian
newborns. The adult mammary gland is structurally composed
of branching ducts that terminate in collections of alveoli, the
milk-producing units (Visvader, 2009; Watson and Khaled,
2008). The histologic organization of the gland involves a bilay-
ered epithelium embedded in mesenchymal stroma, adipose
tissue, and blood vessels (Richert et al., 2000). Two epithelial
compartments comprise the mature gland: luminal cells,
including both ductal and alveolar cells, and basal cells, often
referred to as myoepithelial cells (Hennighausen and Robinson,
2005). The current understanding of the lactating gland empha-
sizes the structural role of ducts, the milk-producing function of
alveolar cells, and a contractile function of basal/myoepithelial
cells in milk ejection (Raymond et al., 2011; Visvader, 2009).DevelopmWhether the basal cells play a more fundamental role in lacto-
genesis has not been established.
Cells of the basal lineage do contribute to the regenerative
capacity of the gland during prepubertal development (Van Key-
meulen et al., 2011; Visvader and Lindeman, 2006; Watson and
Khaled, 2008). Mammary epithelial transplantation experiments
have suggested that a single pluripotent cell within the basal
lineage is capable of reconstituting an entire bilayer gland
(Hennighausen and Robinson, 2005; Visvader and Lindeman,
2006). Consistent with this finding, recent in vivo lineage tracing
experiments have demonstrated that during embryonic develop-
ment a basal epithelial cell progenitor, marked by expression
of Keratin14 (K14), indeed contributes to both basal and luminal
lineages (Van Keymeulen et al., 2011). The role of K14-express-
ing basal cells in the adult gland appears distinct, however,
because lineage-tracing experiments in the unperturbed adult
gland show that K14-positive cells do not contribute to the
luminal cell lineage (Van Keymeulen et al., 2011). Rather, the
mature gland is maintained by separate luminal and basal
unipotent stem-like populations (Van Keymeulen et al., 2011).
Thus, whatever their role during lactogenesis, the endogenous
function of basal epithelia in the adult mammary gland does
not involve a direct contribution to the luminal cell lineage.
During pregnancy, a cascade of hormonal changes initiates
a process of extensive ductal side branching, alveolar prolife-
ration, and differentiation that culminates in milk secretion into
the alveolar lumen (Watson and Khaled, 2008). Genetic experi-
ments over many years have elucidated key signaling pathways
specifically within luminal cells that are essential for pregnancy-
induced development. Among these is prolactin receptor
(PRLR) signaling, as Prlr/ epithelium fails to undergo alveo-
genesis and differentiation of luminal cells, owing to loss of
STAT5A activation (Brisken et al., 1999; Gallego et al., 2001).
In keeping with this result, mammary deletion of Stat5a itself
leads to decreased alveolar proliferation and differentiation
during pregnancy, resulting in failed lactation and death of
pups (Cui et al., 2004; Liu et al., 1997; Yamaji et al., 2009).
Notably, a similar phenotype during pregnancy is observed
following mammary-specific deletion of Erbb4, an epidermal
growth factor (EGF) receptor family member expressed exclu-
sively in luminal cells of the gland (Long et al., 2003; Muraoka-
Cook et al., 2008a). ERBB4 is now known to cooperate with
PRLR signaling to induce activation of STAT5A-dependent
transcription in luminal cells during pregnancy (Muraoka-Cook
et al., 2008b; Williams et al., 2004).ental Cell 28, 147–160, January 27, 2014 ª2014 Elsevier Inc. 147
Figure 1. Basal-Cell-Specific Expression of p63 Increases during Mammary Gland Maturation
(A) Sections of pubertal (6 weeks old), adult virgin (10 weeks old), and lactating mammary gland. Left: hematoxylin and eosin (H&E); right: immunohistochemistry
(IHC) showing basal-specific staining (brown) for p63 and Keratin14. D, duct. Scale bars, 100 mm.
(legend continued on next page)
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Basal Cell Signaling by p63 Controls LactationDespite a relatively detailed understanding of luminal cell
signaling during lactogenesis, a molecular understanding of
how basal epithelial cells might contribute to this process is lack-
ing. We sought to address this knowledge gap by establishing
the mammary phenotype following conditional excision of the
p53 family transcription factor p63 during pregnancy. P63 is a
key developmental factor that is highly expressed together
with K14 selectively in basal epithelia of the adult gland and,
like K14, is often used as a lineage-marker for basal cells
(Van Keymeulen et al., 2011). Expression of p63 is required for
embryonic mammary development, as germline p63/ mice,
which die at birth and lack skin and limbs, also lack even rudi-
mentary mammary glands (Mills et al., 1999; Yang et al., 1999).
Similarly, humans harboring certain germline p63 mutations
exhibit mammary hypoplasia (Rinne et al., 2007; van Bokhoven
et al., 1999, 2001). Outside of this role for p63 in early mammary
development, however, a contribution of p63 to the functional
maturation of the adult mammary gland has not been defined.
Here, we employ a conditional p63 allele and a K14-driven
inducible Cre recombinase transgene to selectively delete p63
in the adult mammary basal epithelium prior to pregnancy.
Loss of p63 exclusively in basal cells leads to a complete failure
of lactation, resulting from blocked luminal cell proliferation and
differentiation, and associated with the accumulation of luminal
progenitor cells. Using multiple in vitro and in vivo models, we
uncover the direct mechanism of these effects. We reveal
NRG1 as a key basal-expressed factor that is transcriptionally
induced by p63 and that is required to mediate luminal pro-
genitor maturation through the activation of ERBB4/STAT5A
signaling. Together these results fundamentally change our
understanding of mammary gland terminal maturation, defining
an essential role for basal-to-luminal signaling via p63 as an
obligate inducer of lactation.
RESULTS
P63 Is Expressed Together with Keratin14 Selectively
in Basal Mammary Epithelia
We first used immunohistochemistry (IHC) to confirm that p63
is highly expressed together with the basal cell marker Keratin14
(K14, encoded by Krt14) selectively in basal epithelia of the
pubertal, adult virgin, and lactating glands (Figure 1A). We then
separated basal and luminal cells for analysis using flow cytom-
etry on disaggregated glands stained for well-established
markers of basal (LinCD24+CD29hi) and luminal (LinCD24+
CD29lo) epithelia (Figures 1B–1D and Figure S1A available
online) (Shackleton et al., 2006; Sleeman et al., 2006). Analysis
of Krt14 and p63 mRNA confirmed the IHC staining, showing
exclusive expression of Krt14 in the basal compartment together
with p63, while both were nearly undetectable in luminal cells
and nonepithelial cells (Figures 1E, S1B, and S1C). The p63(B–D) Representative flow cytometry dot plot showing basal/luminal cell selectio
population of pubertal (B), adult virgin (C), and lactating (D) gland. NE, nonepithe
(E) Mean mRNA levels of Keratin14 (Krt14), Keratin18 (Krt18), p63, and DNp63 in
(Bas.), luminal (Lum.), and nonepithelial (NE) populations sorted as in (D). Data re
(F) Relative mRNA ratio of DNp63/TAp63 of 6-week-old pubertal (n = 3) and L1 (
(G) Mean p63 mRNA levels relative to Gapdh in sorted basal and luminal cells of
In (E)–(G), data represent mean ± SEM. *p < 0.05; **p < 0.01. NS, not significant.
Developmtranscription unit is expressed as multiple protein isoforms,
most notably through two different promoters producing
TAp63 and DNp63 isoforms that contain and lack, respectively,
an N-terminal transactivation domain (Yang et al., 1998). Consis-
tent with results in other epithelial tissues, the vast majority of
p63 expressed in the mammary gland at all adult postnatal
stages is DNp63 (Figures 1F, S1B, and S1C) (Parsa et al.,
1999). Lastly, we examined the relative expression of p63 at
the different postnatal stages of mammary gland development.
Remarkably, we found that p63 expression in sorted basal
cells was consistently highly upregulated between puberty and
lactation (Figures 1G and S1D). Thus, p63 is expressed
selectively in basal mammary epithelia and is increased during
mammary gland maturation.
Lactation Failure Results from Inducible Conditional
Deletion of p63 in Basal Epithelia during Pregnancy
In order to evaluate the potential contribution of p63 to preg-
nancy-associated mammopoiesis, we employed a well-vali-
dated conditional p63 allele (p63L/L) (Keyes et al., 2005). Global
Cre-mediated recombination of this allele in homozygous p63L/L
mice during embryogenesis recapitulates both the genomic
structure and the phenotype of the p63 null mouse (Keyes
et al., 2005). We crossed p63L/L mice to a transgenic strain ex-
pressing the Cre recombinase/estrogen receptor fusion protein
from the K14 promoter (hereafter, K14-CreER) (Vasioukhin
et al., 1999), allowing us to control p63 excision in a temporal-
specific manner. We used tamoxifen treatment to excise p63,
then waited 2–3 weeks thereafter to initiate matings in order to
avoid potential effects of tamoxifen on fertility (Figure 2A). The
K14-CreER transgene was expressed selectively within basal
epithelia as anticipated (Figure 2B); this allows excision of p63
exclusively within the basal compartment, as recent lineage-
tracing experiments have demonstrated that K14-positive cells
do not contribute to the luminal lineage in the adult gland
(Van Keymeulen et al., 2011). Effects on lactogenesis were
then assessed by comparing postpartum p63L/L;K14-CreER
(hereafter, p63-cKO) mice to two control cohorts: p63L/L and
p63+/+;K14-CreER mice. Notably, all control and experimental
mice underwent tamoxifen treatment. As expected, excision of
p63 genomic DNA was observed in total mammary epithelia
(Figure 2C), but not in luminal cells (Figure 2D), and resulted in
substantial downregulation of p63 mRNA and protein (Figures
2E, S2A, and S2B).
A significant mammary phenotype was immediately sug-
gested by the fact that virtually all p63-cKO females failed to
lactate, as evidenced by the complete lack of milk within the
stomachs of the pups, resulting in their death (Figure 2F).
(Of note, matings were carried out with wild-type males, litter
sizes were normal, and pups were morphologically intact at
birth.) The explanation for lactation failure was apparent uponn by CD24 and CD29 expression in the viable, Lin (TER119CD34CD45)
lial.
lactating gland determined by quantitative RT-PCR relative to Gapdh in basal
present mean of three animals.
n = 9) control mice.
pubertal (n = 8), virgin (n = 12) and lactation stage 1 (L1; n = 7) animals.
See also Figure S1.
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Figure 2. Basal Cell p63 Is Required for Lobuloalveolar Development and Lactation
(A) Schematic representation of experimental setup to excise p63 in basal epithelial cells of the mammary gland from female mice during pregnancy by tamoxifen
injection before mating.
(B) Mean mRNA levels of transgenic K14-Cre recombinase relative toGapdh in sorted basal and luminal cells of control nontransgenic (WT; n = 3) and transgenic
p63-cKO (Tg; n = 4) mice at lactation stage 1. ND, not detectable.
(C) Mean p63 DNA Cre/Lox-mediated excision determined by quantitative PCR relative to a control locus in total mammary tissue of control (Ctl; n = 3) and p63-
cKO (n = 6) mice.
(legend continued on next page)
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Basal Cell Signaling by p63 Controls Lactationwhole mount staining and histologic analysis of p63-cKO
postpartum glands, which showed a dramatic paucity of lobu-
loalveolar development compared to controls (Figures 2G–2I).
Furthermore, the extant alveoli in p63-cKO mice were dramati-
cally smaller than controls and lacked the typical appearance
of milk-filled structures (Figures 2I and 2J). Thus, loss of p63
expression exclusively within basal epithelia of the adult gland
is associatedwith a striking failure of lobuloalveolar development
during pregnancy.
Basal p63 Is Required for Luminal Proliferation,
Differentiation, and Luminal Progenitor Maturation
during Pregnancy
More detailed analysis revealed that the phenotype associated
with p63 loss results from a profound lack of both proliferation
and differentiation within alveoli of p63-cKO mice. Thus, sub-
stantially reduced Ki67 staining was observed in p63-cKOmam-
mary epithelia (Figure 3A). A severe failure of differentiation was
also apparent in these glands, indicated by a near-complete
absence of milk gene mRNA and protein expression (Figures
3B and 3C). We then examined the fate of basal cells in these
developmentally arrested glands. We found no evidence for
substantial loss of basal cells following p63 excision, as we
saw little or no difference in the ratio of basal to luminal cells
assessed by flow cytometry in p63-cKO compared to control
glands (Figures 3D and S3A). Consistent with this result, no
excess cell death was evident in either the luminal or basal cell
compartment in p63-cKO versus control glands (Figure S3B).
Furthermore, the basal layer was histologically intact in p63-
cKO glands as evidenced by K14 IHC (Figure S3C).
To unveil the physiological basis for this phenotype, we next
analyzed the fate of committed luminal progenitors, the key
proliferative cells that give rise to terminally differentiated, milk-
producing alveolar cells during pregnancy (Asselin-Labat et al.,
2007). In normal mice, these cells, defined as LinCD24+
CD29loCD61+, are abundant in the adult virgin gland but decline
dramatically during pregnancy (Asselin-Labat et al., 2007).
Indeed, we observed only a small fraction of luminal progenitors
in control mice at the end of pregnancy. Remarkably, however,
these progenitors were substantially more numerous in the
glands of p63-cKO mice (Figures 3E, 3F, S3D, and S3E). We
then performed a functional assay for luminal progenitors,
assessing the ability to form colonies when plated ex vivo in
Matrigel plus growth factor-supplemented (complete) medium
(Asselin-Labat et al., 2007). Consistent with prior reports that
luminal progenitor proliferative capacity is expended at the end
of pregnancy (Asselin-Labat et al., 2007), postpartum control
luminal cells produced only a few tiny colonies (Figure 3G). In(D) Absence of p63 DNA excision in sorted luminal cells of p63-cKO (n = 3) relat
(E) Mean p63 mRNA levels relative to Gapdh in sorted basal cells from control (n
(F) Left: pictures of a pup of a control mother (top) with white stomach and a pup of
pups born with white stomach of control (Ctl, n = 14 pups) and p63-cKO mother
(G and H) Representative whole mount staining of pregnant (L1) mammary glands
showing regions that are enlarged in (H). Scale bars, 5 mm (G) and 1 mm (H).
(I) Representative H&E staining of L1 mammary glands from control (top) and p6
lumen.
(J) Mean filling of fat pad by alveoli (left) and relative area per alveolus (right) of c
All graphs represent mean ± SEM. **p < 0.01; ***p < 0.001. NS, not significant. S
Developmstriking contrast, luminal cells from p63-cKO mice formed
numerous colonies that were on average nearly 50 times larger
than those in the control population at parturition (Figures 3G
and 3H) and were comparable in size to colonies from luminal
cells of wild-type virgins (not shown). Colony growth from p63-
cKO mice required the addition of complete medium, as it did
not occur in Matrigel alone (not shown). Given that luminal cells
themselves from p63-cKO mice do not exhibit p63 excision
(Figure 2D), our data collectively lead to two important conclu-
sions. First, p63 appears to be required through a non-cell-
autonomous mechanism for maturation of luminal progenitors
during pregnancy. Second, these luminal progenitors are
reversibly blocked in their developmental capacity and can be
induced to undergo marked expansion ex vivo when supplied
with exogenous factors.
P63 Is a Direct Transcriptional Regulator Required
for NRG1 Expression in Basal Mammary Epithelia
Based on these findings, we hypothesized that p63might induce
expression of a factor secreted from basal cells that is essential
for lactogenesis. To identify such a factor, we first performed
in silico analyses of existing Gene Expression Omnibus (GEO)
data sets for both p63-dependent gene expression profiling
and chromatin immunoprecipitation high-throughput sequenc-
ing (ChIP-seq) (Barton et al., 2010). By examining the overlap
of these two genome-wide data sets, we aimed to identify fac-
tors directly regulated by p63. Well-established p63 transcrip-
tional targets were identified by this approach, including genes
involved in cell adhesion (Carroll et al., 2006) and FGFR2
signaling (Ferone et al., 2012). Most notably, a single secreted
gene with a potential role in mammary biology emerged from
this analysis, the EGF family member Nrg1 (neuregulin, heregu-
lin-alpha). Nrg1 was not previously known to be produced by
basal epithelia, nor was it established as a bona fide transcrip-
tional target of p63. However, mice lacking alpha isoforms
of NRG1 survive to adulthood but exhibit defective lactation
(Li et al., 2002).
Previous work had suggested that Nrg1 might be expressed
exclusively in mammary stroma (Jones et al., 1996; Yang et al.,
1995). However, we found that Nrg1 is indeed coexpressed
with p63 selectively in sorted basal, but not luminal, epithelial
cells and furthermore that its expression, like that of p63, is
increased during pregnancy (Figure 4A). Most significantly,
Nrg1 mRNA expression in basal cells was substantially down-
regulated along with another established p63-regulated gene
following in vivo excision of p63 (Figure 4B), as was NRG1 pro-
tein (Figure 4C). We next explored p63-dependent regulation
of NRG1 in MCF10A, a nontransformed mammary epithelialive to control (n = 2) mice, determined as in (C).
= 5) and p63-cKO (n = 3) mice.
a p63-cKOmother without milk in its stomach (bottom). Right: quantification of
(n = 15 pups). p value calculated by Fisher’s exact test.
of control and p63-cKO mice. Arrows point to lymph nodes. Squares in (G) are
3-cKO (bottom) mice. Scale bars, 100 mm. D, ductal lumen; asterisk, alveolar
ontrol (n = 6) and p63-cKO (n = 6) mice.
ee also Figure S2.
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Figure 3. Basal p63 Controls Luminal Cell Proliferation, Differentiation, and Luminal Progenitor Maturation during Pregnancy
(A) Proliferation assessed by IHC for Ki67 in representative control and p63-cKO mammary glands at L1. Graph at right shows mean fraction of positive cells in
glands from control (n = 3) and p63-cKO (n = 3) animals. Scale bars, 50 mm.
(B) Absence of milk protein expression (brown) in p63-cKO compared to control mammary glands at L1, shown by IHC. Arrowheads, intraluminal milk protein.
Scale bars, 50 mm.
(C) Mean mRNA expression of whey acidic protein (Wap) and casein beta (Csn2) relative to Gapdh in control (n = 3) and p63-cKO (n = 3) mammary glands at L1.
(D) Little or no difference in the proportion of luminal versus basal cells in control (n = 9) versus p63-cKO (n = 9) glands at L1 assessed by flow cytometry as in
Figure 1.
(E) Increased luminal progenitors in p63-cKO (n = 7) versus control (n = 8) glands at L1, assessed as CD61+ luminal (CD24+CD29lo) cells.
(F) Mean mRNA for Itgb3 (encoding CD61) among sorted control (n = 8) versus p63-cKO (n = 9) luminal cells at L1.
(legend continued on next page)
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Basal Cell Signaling by p63 Controls Lactationcell line that expresses endogenous DNp63 (Carroll et al., 2006).
Expression of NRG1 was nearly completely abolished within
hours following endogenous p63 knockdown via lentivirally ex-
pressed small hairpin RNA (shRNA) in MCF10A (Figures 4D
and 4E). This acute effect on NRG1 following p63 knockdown
suggested potentially direct transcriptional regulation by p63.
Indeed, ChIP analysis for endogenous p63 in these cells re-
vealed robust binding of p63 to a conserved locus upstream of
the NRG1 transcriptional start site (Figures 4F and S4). We
then assessed the requirement for the canonical DNA binding
domain (DBD) of p63 for association with the NRG1 locus. We
overexpressed either wild-type p63 or a DBD point mutant that
does not bind DNA (Moll and Slade, 2004), followed by ChIP.
As predicted, the ectopic wild-type p63 bound to the NRG1
locus, while the point mutant exhibited no binding (Figure 4G).
Finally, we recapitulated these findings in vivo, showing that
endogenous p63 was bound to the Nrg1 locus in the mammary
gland (Figure 4H). Collectively, these data suggest that p63 is
a direct regulator required for NRG1 expression in basal mam-
mary epithelia.
P63 Controls Luminal STAT5A Signaling and
Transcription during Pregnancy
NRG1 functions as a ligand for EGF family receptors, including
ERBB4, although it is unknown whether NRG1 is required for
ERBB4 signaling in the mammary gland in vivo (Muraoka-Cook
et al., 2008a). ERBB4 activation in the mammary gland in turn
activates the signal transducer and activator of transcription
STAT5A (Williams et al., 2004), and conditional deletion of either
Erbb4 or Stat5a induces lactation failure that appears histologi-
cally similar to the phenotype we observe following basal p63
deletion (Long et al., 2003; Yamaji et al., 2009). Therefore, we
hypothesized that defective p63-induced basal NRG1 expres-
sion might lead to a failed paracrine circuit for luminal ERBB4/
STAT5A activation. To test this hypothesis, we first established
that Erbb4 is expressed exclusively in luminal epithelia, in
contrast to p63 and Nrg1, and that p63 excision had no effect
on endogenous Erbb4 levels (Figures 5A, S5A, and S5B). We
then assessed pathway activation, evidenced by accumulation
of phosphorylated STAT5A (pSTAT5A) in the nucleus of luminal
cells within the normal lactating gland (Figure 5B). We next
compared STAT5A activation in control and p63-cKO glands at
parturition. In dramatic contrast to control glands, p63-cKO
glands demonstrated almost no nuclear pSTAT5A staining (Fig-
ures 5C and 5D). These findings are in keeping with the failed
induction we had observed of milk genes, which are key tran-
scriptional targets of STAT5A (Figures 3B and 3C) (Liu et al.,
1996; Yamaji et al., 2013). Additional, functionally important
target genes of STAT5A were also much lower in p63-cKO
glands, including Elf5 and Cyclin D1 (Ccnd1), selectively in
luminal cells (Figure 5E) (Oakes et al., 2008). Thus, loss of basal
epithelial p63 results in failed STAT5A signaling and transcription
in the luminal cell compartment.(G) Increased colony-forming capacity of sorted luminal cells from p63-cKO vers
200 mm.
(H) Quantification of colony-forming capacity. Left: colony number per 1,000 sorte
Right: relative colony volume in cultures from control (n = 4) versus p63-cKO (n =
All graphs represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; NS: not sig
DevelopmWe then sought to establish the direct link between loss of
Nrg1 itself and failed ERBB4/STAT5A signaling during preg-
nancy. To do so, we analyzed in vivo signaling in mice lacking
the mammary-specific alpha isoforms of Nrg1 (Li et al., 2002).
As noted above, these mice have defects in pregnancy-associ-
ated lobuloalveolar development reminiscent of p63-cKO mice,
including condensed and defective alveolar growth, severely
curtailed epithelial proliferation, and deficient differentiation
evidenced by lack of b-casein expression (Li et al., 2002). No
prior analysis of signaling in this mouse had been conducted,
however. Remarkably, we observe a near-complete absence
of phospho-STAT5A staining in the Nrg1a-deficient glands
compared with matched controls (Figure 5F), which phenocop-
ies the loss of staining we observe in p63-cKO mice (Figure 5C).
Taken together, these findings directly link p63 and its regulation
of Nrg1 to failed STAT5A signaling in vivo.
NRG1/ERBB4/STAT5A Signaling Rescues Luminal
Progenitor Maturation and Mammary Reconstitution
following p63 Excision
To further explore the contribution of NRG1 and luminal ERBB4/
STAT5A signaling to p63-dependent lactogenesis, we initially
employed a well-established lactation model, HC11 cells, which
undergo prolactin-dependent differentiation in culture (Taverna
et al., 1991). As it is in vivo, lactogenic differentiation in these
cells is associated with STAT5A activation (Figure 6A). Strikingly,
however, knockdown of p63 in these cells completely abolished
the acute phosphorylation of STAT5A, underscoring the link
between loss of p63 and this signaling pathway (Figure 6A).
Furthermore, while control cells demonstrated the expected
induction of milk gene expression in prolactin-containing
medium, knockdown of endogenous p63 virtually abolished
this effect (Figures 6B and 6C). Thus, p63 is required for STAT5A
signaling and consequent luminal terminal differentiation both
in vitro and in vivo.
In order to establish the contribution of ERBB4/STAT5A
signaling to p63 function in vivo, we focused on the fate of the
endogenous, developmentally arrested luminal progenitor cells
of the p63-cKO animals. Having shown that addition of complete
medium is sufficient to ‘‘rescue’’ proliferation of these progenitor
cells ex vivo (Figure 3G), we asked whether this proliferation was
ERBB4 dependent. Thus, we treated these luminal cell cultures
with two potent ERBB4 inhibitors, JNJ 28871063 hydrochloride
and HDS 029 (Emanuel et al., 2008; Klutchko et al., 2006).
Remarkably, both signaling inhibitors demonstrated a dose-
dependent ability to block proliferation (Figure 6D, top, and
Figure S6A) and STAT5A target gene induction (Figure 6E, left)
within these endogenous progenitors.
Prolactin and ERBB4 signaling cooperate to induce luminal
cell differentiation in vivo (Muraoka-Cook et al., 2008a), and
accordingly we found that the addition of prolactin to complete
medium in the colony-forming assay ‘‘rescued’’ luminal pro-
genitor differentiation ex vivo, as evidenced by high-level milkus control glands at L1, plated in Matrigel plus complete medium. Scale bars,
d luminal cells from control (n = 5) versus p63-cKO (n = 6) glands plated as in (G).
4).
nificant. See also Figure S3.
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Figure 4. Direct Transcriptional Regulation of Nrg1 Expression by p63 during Pregnancy
(A) Nrg1 is expressed in basal epithelia specifically during lactogenesis. Mean mRNA for Nrg1 relative to Gapdh in flow-sorted luminal and basal cells from
pubertal (n = 5), virgin (n = 5), and L1 (n = 7) mammary glands (left) and from pregnancy day 7–9 (P7-9; n = 4), P12-14 (n = 3), and L1 (n = 4) glands (right). ND,
not detectable.
(B) P63-dependent expression ofNrg1 and Jag2, shown relative toGapdh in control (n = 2–4, each in duplicate) versus p63-cKO (n = 2–6, each in duplicate) basal
cells at L1. Data represent mean ± SEM.
(C) Western blot of mammary gland lysates from two representative pregnant control (Ctl) and p63 cKO mice each at L1, showing NRG1 protein is decreased
following conditional p63 excision.
(D) MeanmRNA for p63 and NRG1 relative to beta-2-Microglobulin following p63 knockdown (72 hr) by lentiviral shRNA versus control vector in MCF10A. Shown
is the mean of three independent experiments ±SEM.
(E) Western blot of MCF10A cells showing decreased p63 and NRG1 proteins after transduction with shRNA against p63 in comparison to vector control cells
(corresponds to C). b-tubulin serves as a loading control.
(F) Quantitative PCR (qPCR) analysis of ChIP for endogenous p63 or rabbit control IgG (rIgG) showing specific p63 binding upstream of the NRG1 transcription
start site (TSS; 30 kb), but not to a control locus (21 kB). Shown is the mean of two IP experiments analyzed in duplicate ±SEM.
(G) qPCR analysis of ChIP for FLAG epitope in cells expressing a control vector or FLAG-tagged p63 wild-type (WT) or DNA binding-deficient point mutant
(R304W). Shown is the mean of two ChIP analyzed in duplicate ±SEM. Right: western blot confirming tagged p63 protein expression.
(H) Binding of endogenous p63 to the Nrg1 locus in vivo, shown by qPCR analysis of ChIP for p63 or control rIgG in primary mammary tissue. Shown is the mean
of a representative ChIP analyzed in triplicate ±SD.
*p < 0.05; **p < 0.01; ***p < 0.001. NS, not significant. See also Figure S4.
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Figure 5. P63 Is Essential for Luminal STAT5A Signaling and Transcription during Pregnancy
(A) Mean Erbb4 mRNA levels relative to Gapdh in sorted basal and luminal cells of pubertal (n = 8), virgin (n = 9), and lactation stage 1 (L1; n = 6) animals.
(B) Luminal STAT5A activation shown by immunofluorescence for phosphorylated STAT5A (pSTAT5A) in normal mammary gland at L1. Scale bars, 20 mm.
(C) STAT5A activation assessed by IHC for pSTAT5A (brown) in representative control and p63-cKO mammary glands at L1. Scale bars, 50 mm.
(D) Mean percentage of cells with activated STAT5A in control (n = 5) and p63-cKO (n = 6) glands at L1.
(E) Mean mRNA for STAT5A target genes Elf5 and Ccnd1 relative to Gapdh in flow-sorted luminal and basal cells from control (n = 5–6) and p63-cKO (n = 7–8)
glands at L1. All graphs represent mean ± SEM.; **p < 0.01; ***p < 0.001. NS, not significant.
(F) IHC showing absent pSTAT5A in the postpartum Nrg1a/ mammary gland, which phenocopies failed STAT5A activation in the p63 cKO gland.
See also Figure S5.
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Most importantly, both ERBB4 inhibitors were sufficient to
block STAT5A target gene induction (Figure 6E) and conse-
quently differentiation (Figure 6F) within prolactin-treated endog-
enous progenitors. Collectively, these findings demonstrate
that activation of ERBB4 signaling in luminal cells is required to
overcome blocked progenitor proliferation and differentiation
imposed by failed basal cell p63/NRG1 signaling.
Finally, in order to validate the centrality of NRG1 to the
p63-dependent phenotype, we performed an in vivo rescue
experiment with exogenous NRG1. We collected mammary
epithelia at lactation stage (L1) that had undergone p63 deletionDevelopmprepregnancy as in Figure 2. We then transplanted these cells
into cleared mammary fat pads of recipient mice and treated
the mice with either NRG1 or the control vehicle for 7 weeks.
As expected, the p63-deleted postpartum epithelia were unable
to reconstitute the fat pad of recipient mice in the absence of
NRG1 treatment. Remarkably, however, the NRG1-treated
mice did show reconstitution evidenced by a branching ductal
structure observed on whole-mount staining (Figures S6B
and S6C). As anticipated, the size and extent of outgrowth
observed was characteristic of reconstitution from luminal pro-
genitors (Vaillant et al., 2011). Altogether, these results demon-
strate that p63 directly induces NRG1 expression in basalental Cell 28, 147–160, January 27, 2014 ª2014 Elsevier Inc. 155
Figure 6. P63 and NRG1 Control ERBB4/STAT5A Signaling to Mediate Luminal Progenitor Function and Lactogenesis
(A) Western blot showing p63 is required for phosphorylation of STAT5A in HC11 cells following lentiviral p63 shRNA (shp63) or control vector expression.
(B) RNA for milk genes Csn2 and Wap relative to Gapdh in cells treated as in (A). Shown is the mean of two to four experiments analyzed in duplicate.
(C) P63 regulatesprolactin (Prl)-dependent HC11differentiation, shownbywestern blot for p63 andmilk protein b-casein treated as in (A).b-tubulin, loading control.
(D) Left: representative colony-forming assays of luminal cells from p63-cKO glands as in Figure 3, in the presence or absence of prolactin (Prl) and the ERBB4
inhibitors JNJ and HDS (see text). Scale bars, 500 mm. Right: graphs showing dose-dependent inhibition of luminal progenitor proliferation by ERBB4 inhibitors.
The mean of three experiments is shown.
(E) Mean RNA for Csn2 relative to Gapdh in luminal colonies from (D) in the presence and absence of prolactin and ERBB4 inhibitors. ND, not detectable.
(F) qRT-PCR of ERBB4/STAT5 target gene Elf5 in luminal cells (n = 3–4 each) in Matrigel in presence or absence of ERBB4 inhibitor, 200 nM JNJ 28871063
hydrochloride (JNJ) or 0.5 nM HDS 029 (HDS), with or without lactogenic complete media (Prl) to show that ERBB4 inhibitor blocked its target gene expression.
All graphs represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. NS, not significant. See also Figure S6.
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ERBB4/STAT5A activation that is in turn required for luminal
progenitor expansion, terminal differentiation, and milk produc-
tion (Figure 7).156 Developmental Cell 28, 147–160, January 27, 2014 ª2014 ElseviDISCUSSION
Thewidely acceptedmodel had posited that basal/myoepithelial
cells function in pregnancy essentially as contractile elements toer Inc.
Figure 7. Basal Epithelial p63 Controls
Luminal Progenitor Maturation and Lacto-
genesis through Activation of Paracrine
NRG1/ERBB4/STAT5A Signaling
Left: basal p63 is a direct transcriptional regulator
of Nrg1, encoding a specific ligand for luminal-
specific ERBB4. Right, top: p63- and NRG1-
mediated ERBB4/STAT5A activation, evidenced
by nuclear phosphorylated STAT5A (pS5), induces
luminal progenitor cell proliferation and differen-
tiation resulting in milk production. Bottom: loss of
p63 results in luminal progenitors that are revers-
ibly blocked in development. Cooperating genetic
events may ultimately result in malignant trans-
formation of such progenitors, which are known to
be the precursors of a particularly aggressive form
of breast cancer (see Discussion).
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the contribution of basal epithelia to lactogenesis through induc-
ible conditional deletion of the basal-expressed transcription
factor p63. Previous genetic models of basal/myoepithelial func-
tion during pregnancy have produced variable phenotypes but
have not revealed essential new pathways controlled by these
cells. Conditional deletion of integrin alpha 3 (Itga3) using a
basal-specific Keratin5 (K5)-driven Cre transgene yielded normal
milk production but defective milk ejection, consistent with the
prevailing view of basal cell function (Raymond et al., 2011). In
contrast, deletion of integrin beta 1 (Itgb1) using a K5-driven
Cre transgene affects postnatal viability, and as a result any
effect on the pregnant gland could only be tested in a mammary
transplantation setting (Taddei et al., 2008). Although both mam-
mary epithelial proliferation and differentiation were affected in
this setting, the specific interpretation is somewhat limited by
the fact that basal cells can contribute to the luminal lineage in
such transplants, but not in the native gland (Van Keymeulen
et al., 2011). Finally, deletion of the gene encoding another
basal-specific factor, the Wnt coreceptor LRP5, led to a relative
decrease in basal cells but no clear effect on either pregnancy-
associated proliferation ormilk production (Badders et al., 2009).
We observe that deletion of p63 selectively in basal cells of
the adult gland during pregnancy leads to complete lactationDevelopmental Cell 28, 147–160failure, and we demonstrate that this
phenotype involves dramatic deficits in
both the proliferation and differentiation
of luminal cells. Importantly, we find that
this phenotype is not associated with a
generalized loss of basal cells. Instead,
we provide several lines of evidence
arguing for a specific, non-cell-autono-
mous effect of basal p63 on luminal cell
development. These data include the
selective expression of p63 in basal, but
not luminal, cells in vivo, the absence
of p63 excision in luminal cells and
luminal progenitors despite the dramatic
luminal cell phenotype, and the ability of
blocked luminal progenitor proliferation
and differentiation to be rescued ex vivoin the absence of basal cells. Collectively, our results forge
unanticipated and direct links between basal p63 and non-cell-
autonomous signaling that are essential for lactogenesis. Our
findings therefore overturn the previous paradigm of a limited,
contractile role of basal cells during lactation.
Although p63 is known to play a key role in embryonic
epithelial development, its precise contribution in adult epithelial
tissues has been less well-studied (Keyes et al., 2005; Mills
et al., 1999; Yang et al., 1999). In addition, much of the focus
in adult tissues has been on cell-autonomous functions of p63
(Keyes et al., 2005). Consistent with an important role during
pregnancy, we show that basal cell p63 levels rise during puber-
tal breast development and reach their peak during pregnancy
and lactation. Remarkably, we find that the requirement for
p63 in lactogenesis results from a paracrine basal-to-luminal
signaling axis involving at its root the direct transcriptional acti-
vation of Nrg1 by p63 within the basal epithelia. Although p63
is known to regulate a wide variety of genes, Nrg1 has not
previously been established as a direct transcriptional target
of p63 (Moll and Slade, 2004). Presumably, the stage- and
tissue-specific regulation of Nrg1 by p63 within the pregnant
mammary gland explains why such a fundamentally important
p63 effector genemight have escaped prior notice. It is therefore
tempting to speculate that additional key p63 target genes, January 27, 2014 ª2014 Elsevier Inc. 157
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tions in diverse adult epithelial tissues.
Paracrine signaling is well-established in mammary gland
maturation, yet most previously described mechanisms involve
luminal-to-luminal or luminal-to-basal circuits. For example,
amphiregulin is an important paracrine mediator of proliferation
in response to estrogen stimulation of the luminal compartment
(Ciarloni et al., 2007), andWNT4 and receptor activator of NF-kB
ligand (RANKL) are paracrine factors induced downstream of
luminal-acting progesterone to mediate ductal side branching
and alveogenesis (Brisken et al., 2000; Fata et al., 2000). In
contrast, we reveal a basal-to-luminal axis whereby NRG1 is
expressed in a p63-dependent manner in the basal compart-
ment and acts as an essential paracrine factor for luminal cell
proliferation, differentiation, and lactation. Indeed, a remarkable
feature of this study is our ability to ‘‘connect all the mechanistic
dots’’ defining this paracrine signaling mechanism. We link the
loss of direct p63-driven Nrg1 expression in vivo to a profound
defect in luminal activation of the NRG1 receptor ERBB4, its
signaling partner STAT5A, and the direct STAT5A target gene
Elf5. Notably, genetic ablation of each of these four factors
results in a similar phenotype involving failed luminal proliferation
and differentiation during pregnancy (Li et al., 2002; Long et al.,
2003; Oakes et al., 2008; Yamaji et al., 2009). We provide further
direct evidence implicating this signaling pathway in p63-depen-
dent lactogenesis. Thus, genetic loss of mammary-specific
Nrg1a phenocopies the luminal cell STAT5A signaling defect
seen with conditional basal p63 deletion; NRG1 is sufficient to
rescue engraftment of p63-deleted pregnant mammary epithelia
in vivo, and exogenous growth factors are able to rescue luminal
progenitor proliferation and differentiation in an ERBB4-depen-
dent manner.
Our findings also provide insight into the regulation of luminal
progenitor function, with important implications for both the
normal and diseased mammary gland. Consistent with a prior
report, we find that both the number and proliferative capacity
of luminal progenitors are relatively depleted at the end of a
normal pregnancy (Asselin-Labat et al., 2007). In dramatic
contrast, we find that loss of basal p63 induces a luminal devel-
opmental block resulting in accumulation of these progenitors
at parturition. This block is nonetheless reversible, as it can be
overcome ex vivo as well as in vivo in response to NRG1/
ERBB4-mediated signaling. These data therefore define basal
cells and p63 as essential regulators of luminal progenitor cell
fate and identify luminal progenitors as the key targets of
NRG1-mediated signaling.
This work may in addition be relevant to the emerging concept
of the basal cells as tumor suppressors in the mammary gland
(Polyak and Kalluri, 2010). In carriers of germline BRCA1 muta-
tions, striking cancer predisposition is associated with altered
basal cell numbers and the appearance of a population of
deregulated luminal progenitor cells, which are now thought to
be the precursors of the aggressive, so-called basal-like breast
cancers that occur in these patients (Lim et al., 2009; Proia
et al., 2011). Thus, one step in the evolution of these cancers
may be a failure of luminal progenitor differentiation resulting
from defective basal-to-luminal signaling. We speculate that
additional genetic events may cooperate with basal-dependent
luminal progenitor dysfunction to drive malignant transforma-158 Developmental Cell 28, 147–160, January 27, 2014 ª2014 Elsevition. Elucidating the contribution of the signaling mechanism
we have uncovered to breast cancer pathogenesis in this setting
may therefore have important implications for both prevention
and therapy of this disease.
EXPERIMENTAL PROCEDURES
Cell Lines
MCF10A, 293T, and HC11 cells were maintained as previously described
(Carroll et al., 2006; Taverna et al., 1991). Cell line HC11 (Taverna et al.,
1991) was a generous gift of Joseph Jerry (Pioneer Valley Life Sciences
Institute, Springfield). Each cell line was maintained by the MGH Center for
Molecular Therapeutics cell line bank and underwent high-density SNP typing,
revealing that each was unique compared to >800 other banked lines (Garnett
et al., 2012).
Animal Studies
All animals were housed and treated in accordance with protocols approved
by the Subcommittee on Research Animal Care at the Massachusetts General
Hospital. p63L/L and K14-CreERmice have been previously described (Keyes
et al., 2005; Vasioukhin et al., 1999). In order to excise p63, mice were treated
once per day with 75 mg/kg tamoxifen (Sigma) dissolved in sunflower seed oil
(Sigma) by intraperitoneal injection for 5 consecutive days. Nude mice were
injected intraperitoneally with 80 ng/g recombinant human NRG1 EGF domain
small peptide (peptide Thr176-Lys246, R&D Systems) or the solvent (vehicle,
0.2% (w/v) BSA in PBS) daily for in total 7 weeks. Injections were started
6 days after cell transplantation to allow the mice to recover.
Mammary Cell Preparation, Cell Sorting, and Transplantation
Assays
The thoracic and inguinal mammary glands were dissected from pubertal,
adult virgin females, or pregnant mice at the indicated time points. Single-
cell suspensions were prepared using EpiCult-B Medium for mousemammary
epithelial cell culture (Stem Cell Technologies) following manual instructions.
Fluorescence-activated cell sorting (FACS) analysis and cell sorting were per-
formed as described elsewhere (Shackleton et al., 2006; Sleeman et al., 2006)
using FACS Aria (Becton Dickinson). For transplantation studies, 40,000 mam-
mary epithelial cells (LinCD24+) were sorted, resuspended in 1:1 complete
EpiCult-B Medium media:Matrigel solution (Stem Cell Technologies and BD
Pharmingen, respectively), and transplanted into the cleared number four
inguinal glands of 3-week-old nude recipient mice, as described previously
(Shackleton et al., 2006).
Colony Formation Ex Vivo in Matrigel
For colony-formation assays, freshly sorted luminal cells (20,000) were
embedded in Matrigel (BD Pharmingen) and seeded in 24-well plates as
described previously (Shackleton et al., 2006). Colonies were counted and
measured after 13 days of growth. Afterward, cells were isolated by incubation
of the Matrigel with Dispase (Stem Cell Technologies) for 30 min at 37C and
RNA and genomic DNA was isolated by TRIzol following the manufacturer’s
instructions.
Statistics
p values were determined using the Student’s unpaired t test unless indicated
otherwise.
SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
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